SYSTEMATIC REVIEW AND META - ANALYSIS OF THE FREQUENCY AND RE-CLASSIFICATION TRENDS OF PEDIATRIC INFLAMMATORY BOWEL
Rishi Bolia1, Akhil Dhanesh Goel2
1Department of Gastroenterology, Hepatology and Liver Transplant, Queensland Children's Hospital, Brisbane, Australia.
Inflammatory bowel disease-unclassified (IBDU) affects 7.1% of pediatric patients. Half of these children are later reclassified as ulcerative colitis (UC) or Crohn's disease (CD).
Area of Science:
- Gastroenterology
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Inflammatory bowel disease-unclassified (IBDU) describes chronic colitis lacking definitive classification as ulcerative colitis (UC) or Crohn's disease (CD).
- A significant proportion of pediatric IBDU cases are reclassified upon further observation.
- Variability exists in published data regarding the frequency and reclassification rates of pediatric IBDU.
Approach:
- A systematic literature search was conducted on PubMed and Scopus for studies published between January 2014 and July 2021.
- Two independent reviewers selected studies reporting on the frequency and/or reclassification of pediatric IBDU.
- Meta-analysis using an inverse variance heterogeneity model was employed to pool prevalence data.
Key Points:
- The pooled frequency of IBDU among 16,064 pediatric patients was 7.1% (95% CI 5.8-8.5%).
- Geographical location did not influence the frequency of IBDU.
- In a subset of 5,880 patients, 50% (95% CI 41-60%) of children initially diagnosed with IBDU were reclassified on follow-up.
Conclusions:
- IBDU represents 7.1% of pediatric inflammatory bowel disease diagnoses.
- Approximately 50% of pediatric IBDU cases are reclassified to either UC or CD during follow-up.
- Children with IBDU show a higher likelihood of being reclassified to UC than to CD.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
